Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

June 6, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Page 121

Category: BiotechToday

News

  • BiotechToday
  • World

Phototherapy to Protect Cancer cells

bioxone October 8, 2020October 8, 2020

Subhangi Das, Bankura Sammilani College With the phototherapic development which is also a type of light-induced treatment of cancer, several biomaterials are newly designed as photo-absorbing /sensitizing agents or effecting carriers to enhance the therapeutic efficacy and effective nature of phototherapy. Recently, the immune system responses produced by phototherapy. Which have been explored widely and […]

Read More
  • BiotechToday
  • World

Take care of the Aged – Dementia in the UK

bioxone October 8, 2020October 8, 2020

Rohit Bhattacharjee, Amity University Kolkata Dementia is a pandemic in the ageing society, the likelihood doubles every five years. People with dementia in the UK, both those living with families or alone, have lost invaluable support. Family carers have lost respite opportunities because of COVID-19, causing them to feel abandoned. The burden of care was […]

Read More
  • BiotechToday
  • World

Distance-dependent preferential binding of N2H4 to mobile Lewis acid present in a series of Zn complexes takes place

bioxone October 8, 2020October 8, 2020

Sristi Raj Rai, Amity University Kolkata To feel the protein environment working and its dynamic nature, one needs to collect as much information possible about the acidic/basic residues which make them. A group of enzyme proteins called metalloenzymes has these residues present within the secondary coordination sphere of their active site. Synthetic modelling of acidic […]

Read More
  • BiotechToday
  • World

Use of semi-permeable capsules in multi-step processing of single cells

bioxone October 8, 2020October 7, 2020

Soumya Sarathi Ganguly, Indian Institute of Technology, Kharagpur Droplet microfluidic technologies can be used to isolate and process millions of single cells, but it fails to include molecular biology and cell-based phenotypic assays. Here, we can use a semi-permeable hydrogel capsule based on a microfluidic-based technique to simultaneously isolate and process millions of cells. The […]

Read More
  • BiotechToday
  • World

ANIMAL-FREE MONOCLONAL ANTIBODY- A SUBSTITUTE FOR HYBRIDOMA TECHNOLOGY?

bioxone October 8, 2020October 7, 2020

PRIYANKA CHAKRABORTY, AMITY UNIVERSITY KOLKATA Hybridoma Technology is known for its’ large-scale production of identical antibodies. Recently, the European Commission’s Joint Research Centre (EC-JRC) urged the government to allow the development of animal-free antibodies for the production of vaccine development. This came after the work done by the Scientific Advisory Committee (ESAC) and claims were […]

Read More
  • BiotechToday
  • India
  • World

COVID-19 or flu? Which one to control first?

bioxone October 7, 2020October 7, 2020

Camelia Bhattacharyya, Amity University Kolkata Amidst the pandemic prevailing recently due to the SARS-CoV-2, there is something which still can’t be ignored, the flu which leads to thousands of deaths in the US and infects about 11% of the population each year according to CDC. With the arrival of the flu along with the COVID-19, […]

Read More
  • BiotechToday
  • World

Facilitated Diffusion of Proline across Membranes of Liposomes and Living Cells by a Calix[4]pyrrole Cavitand

bioxone October 7, 2020October 7, 2020

Parnad Basu, Amity University Kolkata The metabolism of cells, transporting amino acids across the cell’s membrane is an integral part of the process. Many pieces of research suggest that serious diseases like cancer (abnormal cell division), cystic fibrosis (a hereditary disease affecting the lungs and digestive system), aminoaciduria (urine contains a high number of amino […]

Read More
  • BiotechToday
  • World

Can PRESENCEOF HYALURONAN be used as a treatment option in COVID19 patients?

bioxone October 7, 2020October 7, 2020

Arpita Adhikary, Amity University Kolkata Deterioration of the respiratory system mainly the lungs is prominent in SARS COVID-19. An active agent, a jelly-like substance was found in dead COVID 19 patients’ respiratory system.  A novel fact is established by the researchers as they conducted an experiment comparing the diseased lung tissue of COVID patients and […]

Read More
  • BiotechToday
  • World

Appendicitis – Antibiotics or Appendectomy?

bioxone October 7, 2020October 7, 2020

Thota Kanishka Rao, Amity University Kolkata Appendectomy has for quite some time been the standard treatment for appendicitis, even though effective utilisation of anti-microbial therapy as an option was accounted for over 60 years. Even in recent years, more than 95% of U.S. patients with appendicitis underwent an appendectomy. However, with the ongoing Covid-19 pandemic, […]

Read More
  • BiotechToday
  • India

SIGN TO START PHASE 1 HUMAN TRIAL OF “ANTISERA”-DCGI

bioxone October 7, 2020October 7, 2020

Aishila Kar, Amity University Kolkata ICMR officials said on Tuesday that The Drugs Controller General of India has given authorization for conducting Phase-1 human clinical trial for an “antisera” that was developed by injecting inactivated SARS-CoV-2 in horses and can be a treatment for COVID-19. The Indian Council of Medical Research (ICMR) in alliance with a Hyderabad-based vaccine maker […]

Read More

Posts navigation

1 … 117 118 119 120 121 122 123 124 125 … 137

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy